Kaposi's sarcoma and the acquired immunodeficiency syndrome.
This review has briefly summarized the place of KS in the AIDS epidemic, offering a framework for more critical evaluation of difficult therapeutic decisions. It should be expected (and it is hoped) that with the current rapid pace of AIDS research, many of these issues will be resolved shortly, and that therapy will become more rational. Until then, however, conventional approaches will be used. Given the hazards of these, it is incumbent upon the physician to remain up to date on developments in this rapidly evolving field.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D017977:Deltaretrovirus; D006801:Humans; D008297:Male; D012514:Sarcoma, Kaposi / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D012878:Skin Neoplasms / Q000209:etiology / Q000473:pathology / Q000628:therapy
D000970:Antineoplastic Agents; D000998:Antiviral Agents